Drug application
AMMONIA N 13 (AMMONIA N-13)
Drugs@FDA ANDA 204514 · JOHNS HOPKINS UNIV
Key facts
| Drug name | AMMONIA N 13 |
|---|---|
| Active ingredients | AMMONIA N-13 |
| Application type | ANDA |
| Application number | 204514 |
| Company | JOHNS HOPKINS UNIV |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Aug 19, 2014 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.